SYSTEMATIC REVIEW REGISTER
JBI has developed a collection of world-class resources driven by the needs of health professionals and consumers worldwide.
Registration of Systematic Review Titles
Please note: this register is for the use of JBI affiliated entities ONLY. Registration of a systematic review title on the JBI website is to promote collaboration between affiliated entities via highlighting current work to other JBI review authors and to recognise that the registered topic is currently in development to avoid any unintended and/or unnecessary duplication of research effort.
Registered systematic reviews that are currently underway are listed below. Protocols for these reviews may already be published or in preparation for publication within six months of initial registration. To avoid duplication, titles in this list should not be replicated by other review authors. Please contact the listed Primary Reviewer or the JBI Synthesis Science Unit if you would like further information about any of these registered reviews.
Registration of titles on this web page does not in any way constitute acceptance of the topic by JBI Evidence Synthesis.
|Title||Certified authors||Collaborating Entity or Institution||Date registered||Custom text|
|A scoping review to explore measures of chest health in children with neurodisability||Rachel Knight Lozano||The University of Plymouth Centre for Innovations in Health and Social Care: A JBI Centre of Excellence||2021-09-06||
The University of Plymouth Centre for Innovations in Health and Social Care: A JBI Centre of Excellence
Rachel Knight Lozano
This review will include children aged 1-18 years with a neurodisability, described by Morris et al. (2013) as a group of congenital or acquired long-term conditions that are attributed to impairment of the brain and/or neuromuscular system and create functional limitations. A specific diagnosis may not be identified. Conditions may vary over time, occur alone or in combination, and include a broad range of severity and complexity. The impact may include difficulties with movement, cognition, hearing and vision, communication, emotion, and behaviour.
The concept of interest is measurement of chest health in children with a neurodisability. Measure of chest health will be defined as a assessment and/or monitoring of lung function and its associated structures. This may be measured at impairment or body structure level, but will also consider measures at activity or participation level, according to the International Classification of Functioning, Disability and Health. The measure may be implemented across any environment or setting, include objective, subjective or combined implementation and encompass measures undertaken by professionals, patients or their caregiver. It will not include invasive measurements.
|Diagnostic overshadowing in the assessment and treatment in people who inject drugs with mental health illness and substance-related disorders infected with hepatitis C virus: a scoping review||Regan Preston||The Western Australian Group for Evidence Informed Healthcare Practice: a JBI Centre of Excellence||2021-08-19||
Diagnostic overshadowing in the assessment and treatment in people who inject drugs with mental health illness and substance-related disorders infected with hepatitis C virus: a scoping review
The Western Australian Group for Evidence Informed Healthcare Practice: a JBI Centre of Excellence
People who inject drugs (PWID) with a mental health illness and substance use related disorders.
Diagnostic overshadowing in the assessment and screening for patients with hepatitis C.